OTC:GWYNF

 genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system LYON, France, Jan. 7, 2020 /PRNewswire/ --?genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic ...

2020-01-07 09:00 3538

Week's Top Stories

Most Reposted

[Picked up by 278 media titles]

2025-09-23 14:45

[Picked up by 277 media titles]

2025-09-24 10:57

[Picked up by 262 media titles]

2025-09-25 09:00

[Picked up by 261 media titles]

2025-09-23 15:14

[Picked up by 238 media titles]

2025-09-26 09:00

Most Read

2025-09-20 12:00 7017

2025-09-20 04:30 6880

2025-09-20 04:25 6277

2025-09-21 06:22 5430

2025-09-20 04:00 5301